Discusses Preclinical Data and Clinical Case Studies on Incorporating Surfactant Bladder Rinse into Treatment October ...

Distributable net investment income is estimated at $0.94-$0.98 per share; full results are due Nov. 5, with a call scheduled ...

In Crohn’s disease, 2% of placebo patients met the steroid-free deep-remission measure. The post-hoc findings will be ...

States are leading the way in providing self-employed workers with opportunities to gain paid leave coverage, but more must ...